Form D · Biotechnology

Peytant Solutions, Inc.

Plymouth, MN · CIK 0001652372

Offering snapshot reported Jan 10, 2025 · SEC filing

Reported sold
$2.89M
Offering amount: $5M
Investors reported
19
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 6, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.45M$2.89MFeb 22, 2023: $900,000.00Feb 22, 2023Jan 11, 2024: $1,545,000.00Jan 11, 2024Jan 10, 2025: $2,890,724.00Jan 10, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$1,545,000 → $2,890,724
  • Reported investors8 → 19

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 10, 2025Amendment$2,890,724$1,345,724vs Jan 11, 202419SEC filing
Jan 11, 2024Amendment$1,545,000$645,000vs Feb 22, 20238SEC filing
Feb 22, 2023Initial$900,000No comparison3SEC filing
Mar 24, 2021Initial$275,005No comparison3SEC filing
Oct 26, 2017Amendment$1,160,000$300,000vs Aug 31, 201711SEC filing
Aug 31, 2017Initial$860,000No comparison7SEC filing
Sep 3, 2015Initial$576,504No comparison8SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-474060

Source: Form D, filed Jan 10, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Clay Anselmo Director
Jeffrey Chambers Director
Bruce Faulken Director
Steven Healy Director
James Ness Executive
John Schorgl Director, Executive, Promoter
Craig Walker Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
3650 Annapolis Lane #180
Plymouth, MN, 55447